Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls

Perkins, Rebecca B.; Zisblatt, Lara; Legler, Aaron; Trucks, Emma; Hanchate, Amresh; Gorin, Sherri Sheinfeld

doi:10.1016/j.vaccine.2014.11.021

Cited by 132 publications

(132 citation statements)

References 26 publications

Supporting

Mentioning

127

Contrasting

Order By: Relevance

“…9,17–19 Qualitative and survey data, as well as some preliminary intervention studies, suggest that many parents may accept the HPV vaccine for their child at 11 to 12 years if their knowledge gaps and concerns are addressed by the physician in conjunction with a strong recommendation for vaccination. 8,20–24 …”

Section: Discussionmentioning

confidence: 99%

Primary Care Physicians’ Perspectives About HPV Vaccine

et al. 2016

View full text Add to dashboard Cite

background and objectives: Because physicians’ practices could be modified to reduce missed opportunities for human papillomavirus (HPV) vaccination, our goal was to: (1) describe self-reported practices regarding recommending the HPV vaccine; (2) estimate the frequency of parental deferral of HPV vaccination; and (3)identify characteristics associated with not discussing it. methods: A national survey among pediatricians and family physicians (FP) was conducted between October 2013 and January 2014. Using multivariable analysis, characteristics associated with not discussing HPV vaccination were examined. results: Response rates were 82% for pediatricians (364 of 442) and 56% for FP (218 of 387). For 11–12 year-old girls, 60% of pediatricians and 59% of FP strongly recommend HPV vaccine; for boys,52% and 41% ostrongly recommen. More than one-half reported ≥25% of parents deferred HPV vaccination. At the 11–12 year well visit, 84% of pediatricians and 75% of FP frequently/always discuss HPV vaccination. Compared with physicians who frequently/always discuss, those who occasionally/rarely discuss(18%) were more likely to be FP (adjusted odds ratio [aOR]: 2.0 [95% confidence interval (CI): 1.1–3.5), be male (aOR: 1.8 [95% CI: 1.1–3.1]), disagree that parents will accept HPV vaccine if discussed with other vaccines (aOR: 2.3 [95% CI: 1.3–4.2]), report that 25% to 49% (aOR: 2.8 [95% CI: 1.1–6.8]) or ≥50% (aOR: 7.8 [95% CI: 3.4–17.6]) of parents defer, and express concern about waning immunity (aOR: 3.4 [95% CI: 1.8–6.4]). conclusions: Addressing physicians’ perceptions about parental acceptance of HPV vaccine, the possible advantages of discussing HPV vaccination with other recommended vaccines, and concerns about waning immunity could lead to increased vaccination rates.

show abstract

Section: Discussionmentioning

confidence: 99%

Primary Care Physicians’ Perspectives About HPV Vaccine

et al. 2016

View full text Add to dashboard Cite

show abstract

“…79 Perkins et al compared HPV vaccination rates at clinics randomized to the AFIX approach versus control clinics and demonstrated significantly increased HPV uptake, most impressively among boys. 39 Gilkey et al randomized 91 clinics to 3 groups: in-person AFIX consultation, webinar AFIX consultation, or control. HPV completion rates were highest among clinics that received an in-person AFIX consult.…”

Section: Behavioral Interventions: Providertargeted Interventions (N mentioning

confidence: 99%

Interventions to Improve HPV Vaccine Uptake: A Systematic Review

Walling¹,

Benzoni²,

Dornfeld³

et al. 2016

Pediatrics

193

154

View full text Add to dashboard Cite

CONTEXT: The human papillomavirus (HPV) vaccine is a safe, effective cancer prevention method that is underutilized in the United States. Despite increased understanding of barriers to vaccination, rates remain low. Globally, developed and developing nations have achieved high rates of vaccination.OBJECTIVE: Identification of effective strategies is necessary to optimize uptake of the HPV vaccine. We systematically reviewed the literature for national and international interventions that have successfully increased HPV vaccine uptake. DATA SOURCES:We used a standardized protocol to search for articles published between January 1, 2006, and April 30, 2015, in 3 electronic databases: PubMed, Scopus, and Embase. STUDY SELECTION:We identified interventions designed to increase HPV vaccine uptake among adolescents and young adults aged 11 to 26 years. All study designs were acceptable. Only articles that included postintervention vaccination rates were included. DATA EXTRACTION:Two authors independently reviewed each article for data extraction and quality assessment. Interventions were classified according to the Community Preventive Service Task Force guide. RESULTS:Results were reported according to the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework. Fifty-one articles met eligibility criteria: 2 informational interventions, 18 behavioral interventions, and 31 environmental interventions. Factors associated with HPV vaccine uptake were increased vaccine availability, decreased financial barriers, and interventions targeting both providers and patients.LIMITATIONS: Lack of consistent RE-AIM metric reporting, limiting our ability to assess intervention validity and quality.CONCLUSIONS: Population-based vaccination strategies that increased vaccine availability reached the greatest number of adolescents and were most successful in achieving high rates of vaccination.

show abstract

“…Although there was a slight increase in the overall vaccination completion rate in females from the previous year, the rate of uptake for HPV vaccination continues to lag behind other adolescent vaccines, resulting in a pressing need to identify effective ways of increasing uptake across different populations (Ferrer, Trotter, Hickman, & Audrey, 2014;Fu, Bonhomme, Cooper, Joseph, & Zimet, 2014;Mayne et al, 2012;Perkins et al, 2015).…”

Section: Articlementioning

confidence: 99%

Timing Is Everything: Exploring Parental Decisions to Delay HPV Vaccination

Rendle

Leskinen

2016

Qual Health Res

View full text Add to dashboard Cite

The delayed uptake of the human papillomavirus (HPV) vaccine offers an opportunity to explore how temporality and risk are at work in everyday life. Drawing from a mixed-methods study with parents ( N = 50) in Northern California, this study explored parents' decision to delay HPV vaccination for their children among parents who had not yet vaccinated ( n = 27). At the core of these decisions were temporal assessments of risk whereby parents weighed their child's (perceived) present risk of HPV exposure against the uncertain perceived risks of the vaccine itself. Our findings are promising as they indicate that given time, and the continued growth of evidence regarding the safety and effectiveness of HPV vaccination, completion rates should increase. However, our results also suggest that vaccination delays are not merely a matter of scientific doubt but also based on parents' (potentially inaccurate) perceptions of their child's sexual readiness, and thus potentially more difficult to overcome.

show abstract

Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls

Cited by 132 publications

References 26 publications

Primary Care Physicians’ Perspectives About HPV Vaccine

Primary Care Physicians’ Perspectives About HPV Vaccine

Interventions to Improve HPV Vaccine Uptake: A Systematic Review

Timing Is Everything: Exploring Parental Decisions to Delay HPV Vaccination

Contact Info

Product

Resources

About